60 Degrees Pharmaceuticals, Inc. (SXTP), a pharmaceutical company focused on infectious diseases, on Wednesday announced it has entered into definitive agreements for the purchase and sale of 1.5 million shares of its common stock for $0.72 per share in a registered direct offering, priced at-the-market under Nasdaq rules.
Additionally, the company will issue unregistered short-term warrants to purchase up to 1.5 million shares of common stock in a concurrent private placement.
The short-term warrants have an exercise price of $0.59 per share and will expire 24 months after issuance.
The aggregate gross proceeds from the offering are expected to be $1.1 million, with the funds primarily allocated for working capital and other general corporate purposes.
The offering is expected to close on or about February 6, 2025.
Currently, SXTP is trading at $0.03 up by 62.39%.
For comments and feedback contact: editorial@rttnews.com
Business News
September 11, 2026 16:26 ET Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.